Screener
Odyssey Therapeutics ODTX MDA5 — Business Combination Contingent Consideration Liability Measurement Input
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Odyssey Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput.
The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335822
| Significant Unobservable Inputs | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Discount rate | 22.1% | 15.6% |
| Projected milestone timing | 3.00 to 11.26 Years | 2.25 to 11.75 Years |
| Probability of milestone achievement - NLRP1 program | 5.0% - 35.0% | 5.0% - 35.0% |
| Probability of milestone achievement - MDA5 program | 5.0% - 35.0% | 5.0% - 35.0% |
Item 1. Financial Statements.
FAQ
- What is Odyssey Therapeutics's MDA5 — business combination contingent consideration liability measurement input?
- Odyssey Therapeutics (ODTX) reported MDA5 — business combination contingent consideration liability measurement input of 3,500% in Q2 2026.
- What does MDA5 — business combination contingent consideration liability measurement input mean?
- This metric represents the key valuation inputs, such as probability-weighted clinical milestones or revenue projections, used to determine the fair value of contingent consideration liabilities associated with the acquisition of the MDA5 program. It reflects the financial obligation owed to former shareholders or partners contingent upon the successful development, regulatory approval, or commercialization of the MDA5-targeted therapeutic. Changes in these inputs directly impact the company's balance sheet and reported earnings through periodic fair value adjustments.
Ask your AI about Odyssey Therapeutics's mda5 — business combination contingent consideration liability measurement input.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude